METHOD FOR FETOPLACENTAL INSUFFICIENCY PREVENTION FOR PREGNANT WOMEN WITH CHRONIC KIDNEY DISEASE Russian patent published in 2017 - IPC A61K31/727 G01N33/48 A61P43/00 

FIELD: medicine.

SUBSTANCE: invention is intended for prevention of fetoplacental insufficiency (FPI) for pregnant women with chronic kidney disease (CKD). An antiaggregant is prescribed at a preventive dose. In addition, pregnant women with pathology interstitial at CKD of stages III-V, glomerulopathies at CKD receive heparin therapy at a preventive dose. For pregnant women with stage II CKD, plasma hemostasis is examined by thrombodynamics and if at least two spontaneous clots are detected during 30 minutes of observation, heparin therapy is carried out at a preventive dose. Further, the state of the plasma hemostasis is monitored by thrombodynamics at least once every 20 days. If at least two spontaneous clots are detected within 30 minutes of observation, the preventive dose of heparin is adjusted upwards.

EFFECT: method allows to provide prevention of fetoplacental insufficiency.

3 ex